Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $9.08 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.18.
Market Cap
9.08T
Revenue
4.66T
Profits
184.56B
PE Ratio
49.18
Profit Margin
3.96%
Dividend Yield
0.39%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 4.86% | 6,445,690 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 620.77B | 1.04% | 6,472,629 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 435.06B | 0.98% | 5,193,732 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 374.84B | 1.28% | 5,399,007 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 316.95B | 0.26% | 10,501,870 | 66.57B |
| 6 | NVS | Novartis AG | 293.01B | 0.76% | 1,177,803 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 251.40B | 3.78% | 7,002,934 | 61.37B |
| 8 | AMGN | Amgen Inc. | 220.49B | 4.57% | 5,750,740 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 213.65B | 2.32% | 1,552,874 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 201.07B | 0.56% | 22,275,740 | 50.34B |
| 11 | ABT | Abbott Laboratories | 182.92B | 0.24% | 9,313,212 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 163.51B | -2.58% | 11,383,394 | 30.46B |
| 13 | PFE | Pfizer Inc. | 147.11B | 1.57% | 47,058,339 | 63.70B |
| 14 | DHR | Danaher Corporation | 140.36B | 2.51% | 3,748,047 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 132.55B | 1.88% | 3,286,391 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 129.98B | -3.43% | 14,117,062 | 49.19B |
| 17 | SYK | Stryker Corporation | 129.28B | 0.32% | 2,031,500 | 25.84B |
| 18 | CVS | CVS Health Corporation | 126.77B | -5.08% | 18,514,645 | 412.65B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 122.89B | 1.28% | 1,383,068 | 12.59B |
| 20 | MDT | Medtronic plc | 110.07B | -0.24% | 4,734,048 | 36.36B |
| 21 | GSK | GSK plc | 103.36B | -0.14% | 2,483,315 | 44.05B |
| 22 | SNY | Sanofi | 103.06B | 0.23% | 2,468,435 | 55.89B |
| 23 | MCK | McKesson Corporation | 102.70B | 5.64% | 1,143,324 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 88.69B | 2.22% | 1,124,746 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 84.85B | 3.50% | 1,165,501 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.75B | 1.04% | 532,483 | 15.53B |
| 27 | CI | The Cigna Group | 71.48B | -1.30% | 4,641,100 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.19B | -2.75% | 16,512,147 | 21.00B |
| 29 | COR | Cencora, Inc. | 61.72B | 3.57% | 2,291,360 | 332.77B |
| 30 | CAH | Cardinal Health, Inc. | 56.03B | 2.43% | 2,650,974 | 250.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 54.98B | 0.97% | 4,865,208 | 28.42B |
| 32 | ARGX | argenx SE | 54.05B | 2.78% | 358,795 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 51.28B | -0.70% | 3,665,538 | 6.51B |
| 34 | MDLN | Medline Inc. | 48.18B | -12.79% | 24,818,166 | 29.94B |
| 35 | BDX | Becton, Dickinson and Company | 47.02B | 0.32% | 2,538,062 | 22.23B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 46.07B | -0.56% | 937,184 | 4.55B |
| 37 | HUM | Humana Inc. | 43.69B | 0.46% | 1,492,827 | 145.68B |
| 38 | HLN | Haleon plc | 43.38B | 1.74% | 8,633,380 | 14.80B |
| 39 | RVMD | Revolution Medicines, Inc. | 41.95B | 1.98% | 1,952,903 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 40.46B | 0.84% | 4,963,167 | 17.32B |
| 41 | A | Agilent Technologies, Inc. | 39.85B | 1.37% | 1,266,395 | 7.23B |
| 42 | NTRA | Natera, Inc. | 39.33B | -0.21% | 1,128,824 | 2.50B |
| 43 | WAT | Waters Corporation | 39.27B | 0.99% | 1,104,540 | 4.64B |
| 44 | IQV | IQVIA Holdings Inc. | 38.85B | 3.44% | 1,557,762 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 37.24B | 1.40% | 476,547 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 34.68B | 0.78% | 1,548,768 | 3.32B |
| 47 | ALC | Alcon Inc. | 34.27B | -0.59% | 1,216,531 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 33.25B | 0.47% | 3,536,502 | 2.54B |
| 49 | CNC | Centene Corporation | 33.09B | 4.56% | 7,034,051 | 180.30B |
| 50 | RMD | ResMed Inc. | 32.32B | 0.40% | 1,746,579 | 5.54B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 31.73B | -0.03% | 2,790,925 | 21.27B |
| 52 | DXCM | DexCom, Inc. | 31.19B | -4.92% | 6,010,497 | 4.97B |
| 53 | ZTS | Zoetis Inc. | 31.19B | -2.17% | 10,181,203 | 9.53B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.60B | 4.44% | 2,734,600 | 4.80B |
| 55 | BIIB | Biogen Inc. | 30.53B | -0.87% | 873,781 | 10.03B |
| 56 | ILMN | Illumina, Inc. | 30.18B | -1.55% | 2,266,096 | 4.49B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.48B | -1.08% | 187,721 | 4.13B |
| 58 | DGX | Quest Diagnostics Incorporated | 26.03B | 0.91% | 674,202 | 11.56B |
| 59 | PHG | Koninklijke Philips N.V. | 25.93B | 0.45% | 952,253 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 25.40B | 0.52% | 502,483 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.89B | 0.03% | 5,856,654 | 7.53M |
| 62 | WST | West Pharmaceutical Services, Inc. | 24.70B | 0.65% | 499,399 | 3.33B |
| 63 | INCY | Incyte Corporation | 24.28B | -0.66% | 1,795,673 | 5.82B |
| 64 | BNTX | BioNTech SE | 23.16B | 0.91% | 1,700,691 | 3.03B |
| 65 | STE | STERIS plc | 22.68B | -0.06% | 923,109 | 6.04B |
| 66 | MRNA | Moderna, Inc. | 22.46B | -1.29% | 5,163,266 | 2.23B |
| 67 | UTHR | United Therapeutics Corporation | 22.26B | 0.06% | 742,762 | 3.15B |
| 68 | GH | Guardant Health, Inc. | 21.90B | 2.12% | 2,396,898 | 1.18B |
| 69 | INSM | Insmed Incorporated | 21.46B | 0.27% | 4,899,603 | 819.56M |
| 70 | THC | Tenet Healthcare Corporation | 21.08B | 3.32% | 1,101,175 | 21.81B |
| 71 | VTRS | Viatris Inc. | 20.55B | -0.28% | 11,351,223 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.99B | 2.45% | 5,480,485 | 8.51B |
| 73 | GMAB | Genmab A/S | 17.94B | 0.83% | 1,404,185 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 16.98B | -0.02% | 715,292 | 4.60B |
| 75 | NBIX | Neurocrine Biosciences, Inc. | 16.42B | -2.75% | 1,292,450 | 3.37B |
| 76 | MEDP | Medpace Holdings, Inc. | 16.41B | 2.20% | 246,169 | 2.78B |
| 77 | ASND | Ascendis Pharma A/S | 16.10B | -0.16% | 486,261 | 998.25M |
| 78 | BBIO | BridgeBio Pharma, Inc. | 16.03B | -0.10% | 2,424,588 | 579.96M |
| 79 | SOLV | Solventum Corporation | 15.15B | -0.53% | 1,554,621 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.60B | 0.20% | 1,507,727 | 4.23B |
| 81 | EXEL | Exelixis, Inc. | 14.25B | 1.25% | 4,202,047 | 2.44B |
| 82 | BAX | Baxter International Inc. | 14.13B | -3.60% | 9,302,602 | 11.47B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.19B | 0.40% | 3,222,602 | 14.37B |
| 84 | ELAN | Elanco Animal Health Incorporated | 13.10B | 2.42% | 13,867,225 | 5.02B |
| 85 | RVTY | Revvity, Inc. | 12.83B | 3.26% | 2,149,569 | 2.91B |
| 86 | PEN | Penumbra, Inc. | 12.73B | -0.31% | 282,961 | 1.50B |
| 87 | FMS | Fresenius Medical Care AG | 12.64B | -0.50% | 1,431,190 | 22.19B |
| 88 | ICLR | ICON Public Limited Company | 12.62B | 4.25% | 617,777 | 8.29B |
| 89 | CRL | Charles River Laboratories International, Inc. | 12.56B | 11.36% | 1,782,425 | 4.00B |
| 90 | SNN | Smith & Nephew plc | 12.56B | -1.02% | 1,572,613 | 6.30B |
| 91 | ALGN | Align Technology, Inc. | 12.52B | 0.90% | 1,020,302 | 4.14B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.28B | -2.99% | 1,703,441 | 669.50M |
| 93 | DVA | DaVita Inc. | 12.03B | -17.24% | 3,814,934 | 14.01B |
| 94 | CORT | Corcept Therapeutics Incorporated | 11.97B | 0.81% | 846,860 | 830.81M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.88B | 1.29% | 349,535 | 1.28B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.58B | -1.33% | 1,685,605 | 3.24B |
| 97 | TECH | Bio-Techne Corporation | 11.22B | -0.12% | 1,778,408 | 1.21B |
| 98 | EHC | Encompass Health Corporation | 11.00B | 0.36% | 1,306,335 | 6.21B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 10.95B | 0.32% | 665,358 | 708.24M |
| 100 | GMED | Globus Medical, Inc. | 10.93B | -1.19% | 1,394,474 | 3.10B |
| 101 | ABVX | ABIVAX Société Anonyme | 10.86B | 0.16% | 660,074 | 5.67M |
| 102 | SMMT | Summit Therapeutics Inc. | 10.79B | -1.67% | 3,154,634 | - |
| 103 | CYTK | Cytokinetics, Incorporated | 10.71B | 0.31% | 1,594,168 | 105.82M |
| 104 | UHS | Universal Health Services, Inc. | 10.39B | 2.26% | 721,426 | 18.11B |
| 105 | ENSG | The Ensign Group, Inc. | 10.32B | 1.43% | 309,599 | 5.49B |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.28B | 0.33% | 2,528,916 | 3.50B |
| 107 | MOH | Molina Healthcare, Inc. | 10.17B | 1.98% | 645,913 | 42.47B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.03% | 1,961,062 | - |
| 109 | GKOS | Glaukos Corporation | 10.08B | 0.23% | 705,743 | 612.84M |
| 110 | HSIC | Henry Schein, Inc. | 9.98B | 0.54% | 1,637,728 | 13.60B |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.91B | 0.43% | 1,262,675 | 1.51B |
| 112 | KRYS | Krystal Biotech, Inc. | 9.64B | 0.31% | 324,613 | 440.48M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.30B | 4.50% | 522,124 | 2.59B |
| 114 | PODD | Insulet Corporation | 9.23B | -20.12% | 7,177,705 | 3.05B |
| 115 | SYRE | Spyre Therapeutics, Inc. | 9.20B | -0.56% | 1,037,497 | - |
| 116 | OSCR | Oscar Health, Inc. | 9.07B | -0.89% | 6,509,819 | 15.32B |
| 117 | AVTR | Avantor, Inc. | 9.04B | -2.34% | 9,571,603 | 6.56B |
| 118 | IONS | Ionis Pharmaceuticals, Inc. | 9.01B | -1.60% | 2,122,268 | 874.09M |
| 119 | RGEN | Repligen Corporation | 8.95B | 5.88% | 1,281,865 | 785.10M |
| 120 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.91B | 0.17% | 2,866,831 | 42.16M |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.90B | 2.95% | 274,915 | 7.46M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.83B | 1.11% | 430,529 | 281.99M |
| 123 | HQY | HealthEquity, Inc. | 8.73B | -0.53% | 559,148 | 1.34B |
| 124 | ATR | AptarGroup, Inc. | 8.69B | 0.42% | 454,848 | 3.93B |
| 125 | KYMR | Kymera Therapeutics, Inc. | 8.68B | 1.04% | 586,318 | 105.00M |
| 126 | QGEN | Qiagen N.V. | 8.68B | -0.90% | 2,037,988 | 2.10B |
| 127 | TEM | Tempus AI, Inc. | 8.43B | -0.74% | 3,507,416 | 1.43B |
| 128 | ALKS | Alkermes plc | 8.32B | -0.12% | 1,706,770 | 1.67B |
| 129 | IMVT | Immunovant, Inc. | 8.11B | -0.20% | 1,522,286 | - |
| 130 | PCVX | Vaxcyte, Inc. | 8.07B | 2.25% | 886,281 | - |
| 131 | BRKR | Bruker Corporation | 7.99B | 4.31% | 4,797,963 | 3.50B |
| 132 | LQDA | Liquidia Corporation | 7.93B | 0.84% | 932,301 | 288.07M |
| 133 | IBRX | ImmunityBio, Inc. | 7.68B | 4.32% | 11,508,347 | 165.79M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.62B | 4.66% | 1,087,054 | 239.92M |
| 135 | HIMS | Hims & Hers Health, Inc. | 7.33B | -1.59% | 8,377,399 | 2.37B |
| 136 | PACS | PACS Group, Inc. | 7.23B | 1.85% | 2,350,936 | 5.55B |
| 137 | COGT | Cogent Biosciences, Inc. | 7.22B | -1.33% | 1,881,063 | - |
| 138 | TWST | Twist Bioscience Corporation | 7.21B | 15.65% | 3,295,401 | 431.80M |
| 139 | CHE | Chemed Corporation | 7.11B | 1.26% | 186,362 | 2.60B |
| 140 | TGTX | TG Therapeutics, Inc. | 7.07B | 2.34% | 2,841,382 | 799.54M |
| 141 | GRFS | Grifols, S.A. | 7.03B | -1.73% | 442,840 | 8.48B |
| 142 | BLLN | BillionToOne, Inc. | 6.90B | 5.43% | 922,058 | 397.41M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.61B | 0.39% | 2,015,199 | 1.55B |
| 144 | ERAS | Erasca, Inc. | 6.46B | 1.31% | 3,104,178 | - |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 6.45B | 1.40% | 882,294 | 618.07M |
| 146 | CGON | CG Oncology, Inc. | 6.39B | 1.43% | 922,870 | 5.07M |
| 147 | DNTH | Dianthus Therapeutics, Inc. | 6.29B | 1.90% | 1,051,858 | 1.90M |
| 148 | HNGE | Hinge Health, Inc. | 6.25B | 1.73% | 3,965,684 | 720.06M |
| 149 | BLTE | Belite Bio, Inc | 6.24B | 0.78% | 141,932 | - |
| 150 | XENE | Xenon Pharmaceuticals Inc. | 6.22B | 0.45% | 617,252 | 7.50M |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.09B | 2.75% | 531,387 | 840.85M |
| 152 | TFX | Teleflex Incorporated | 6.06B | -2.38% | 645,246 | 2.25B |
| 153 | TXG | 10x Genomics, Inc. | 6.03B | -0.84% | 2,498,003 | 638.78M |
| 154 | LGND | Ligand Pharmaceuticals Incorporated | 5.99B | 0.59% | 197,095 | 274.48M |
| 155 | BLCO | Bausch + Lomb Corporation | 5.99B | 0.48% | 221,066 | 5.32B |
| 156 | TVTX | Travere Therapeutics, Inc. | 5.92B | 12.03% | 6,308,584 | 591.33M |
| 157 | DFTX | Definium Therapeutics, Inc. | 5.89B | 4.89% | 1,562,457 | - |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.89B | -0.11% | 1,865,070 | 3.12B |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.86B | -0.96% | 639,819 | - |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.78B | 0.16% | 1,102,512 | 1.01B |
| 161 | SRRK | Scholar Rock Holding Corporation | 5.74B | 0.17% | 1,053,064 | - |
| 162 | STVN | Stevanato Group S.p.A. | 5.49B | 2.29% | 414,556 | 1.40B |
| 163 | RDNT | RadNet, Inc. | 5.27B | -3.12% | 605,738 | 2.14B |
| 164 | MMED | MiniMed Group, Inc. | 5.21B | -2.26% | 1,043,498 | 3.10B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.21B | 1.58% | 1,969,644 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.13B | -0.72% | 3,053,686 | 1.22B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.07B | -1.17% | 1,619,793 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.96B | 6.08% | 4,549,298 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.89B | 0.77% | 2,152,619 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.84B | 0.63% | 1,734,456 | - |
| 171 | NVST | Envista Holdings Corporation | 4.66B | 2.40% | 6,998,017 | 2.86B |
| 172 | MANE | Veradermics, Incorporated | 4.65B | 3.78% | 936,182 | - |
| 173 | CAI | Caris Life Sciences, Inc. | 4.65B | 2.17% | 6,766,327 | 989.61M |
| 174 | INDV | Indivior Pharmaceuticals, Inc. | 4.57B | 6.11% | 4,275,247 | 1.33B |
| 175 | CELC | Celcuity Inc. | 4.53B | 0.46% | 772,006 | - |
| 176 | WAY | Waystar Holding Corp. | 4.48B | -1.64% | 2,285,995 | 1.21B |
| 177 | PBLS | Parabilis Medicines, Inc. | 4.44B | -2.79% | 268,959 | - |
| 178 | LIVN | LivaNova PLC | 4.29B | -8.42% | 1,862,519 | 1.47B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.29B | 0.77% | 1,505,669 | 10.68M |
| 180 | ITGR | Integer Holdings Corporation | 4.25B | -0.04% | 1,891,417 | 1.84B |
| 181 | ELVN | Enliven Therapeutics, Inc. | 4.17B | -2.31% | 1,724,209 | - |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.16B | -1.94% | 1,861,478 | 56.99M |
| 183 | ICUI | ICU Medical, Inc. | 4.16B | -3.23% | 325,683 | 2.16B |
| 184 | IRTC | iRhythm Holdings, Inc. | 4.09B | -2.07% | 517,233 | 787.85M |
| 185 | LFST | LifeStance Health Group, Inc. | 4.02B | 1.07% | 4,363,759 | 1.58B |
| 186 | CON | Concentra Group Holdings Parent, Inc. | 3.94B | -1.16% | 1,452,235 | 2.23B |
| 187 | ADPT | Adaptive Biotechnologies Corporation | 3.93B | 0.20% | 2,415,866 | 308.08M |
| 188 | VKTX | Viking Therapeutics, Inc. | 3.91B | 1.73% | 1,960,706 | - |
| 189 | DOCS | Doximity, Inc. | 3.89B | -1.19% | 2,646,869 | 644.86M |
| 190 | DNLI | Denali Therapeutics Inc. | 3.88B | 1.03% | 1,094,214 | - |
| 191 | HAE | Haemonetics Corporation | 3.80B | -2.08% | 1,140,268 | 1.35B |
| 192 | VCYT | Veracyte, Inc. | 3.71B | -0.56% | 1,227,696 | 561.90M |
| 193 | LEGN | Legend Biotech Corporation | 3.69B | -0.42% | 1,704,126 | 1.14B |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.61B | 1.26% | 99,255 | 803.79M |
| 195 | WRBY | Warby Parker Inc. | 3.59B | -2.17% | 4,143,752 | 890.57M |
| 196 | GPCR | Structure Therapeutics Inc. | 3.59B | 1.79% | 713,610 | - |
| 197 | OGN | Organon & Co. | 3.56B | 0.07% | 2,148,190 | 6.13B |
| 198 | OPCH | Option Care Health, Inc. | 3.55B | 0.04% | 2,579,963 | 5.69B |
| 199 | RCUS | Arcus Biosciences, Inc. | 3.48B | -3.82% | 1,043,819 | 117.00M |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | -0.19% | 1,004,923 | 234.13M |
| 201 | NHC | National HealthCare Corporation | 3.46B | 6.36% | 134,390 | 1.53B |
| 202 | ALMS | Alumis Inc. | 3.46B | - | 630,541 | 8.40M |
| 203 | BKD | Brookdale Senior Living Inc. | 3.45B | 1.41% | 3,191,106 | 3.00B |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.39B | 4.11% | 2,448,788 | 463.98M |
| 205 | CLDX | Celldex Therapeutics, Inc. | 3.22B | 5.15% | 788,876 | 865.00K |
| 206 | MBX | MBX Biosciences, Inc. | 3.21B | -4.55% | 487,496 | - |
| 207 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -0.47% | 1,652,567 | 7.12M |
| 208 | GRAL | GRAIL, Inc. | 3.18B | 2.04% | 514,191 | 165.26M |
| 209 | QURE | uniQure N.V. | 3.07B | 1.28% | 799,949 | 18.67M |
| 210 | IRON | Disc Medicine, Inc. | 3.03B | 1.43% | 272,313 | - |
| 211 | PRVA | Privia Health Group, Inc. | 3.02B | 0.71% | 1,199,234 | 2.36B |
| 212 | ACHC | Acadia Healthcare Company, Inc. | 3.00B | 1.80% | 2,621,295 | 3.37B |
| 213 | RGC | Regencell Bioscience Holdings Limited | 2.91B | -2.98% | 301,180 | - |
| 214 | IMNM | Immunome, Inc. | 2.89B | 1.84% | 1,092,755 | 4.02M |
| 215 | ALHC | Alignment Healthcare, Inc. | 2.84B | 1.18% | 5,811,842 | 4.58B |
| 216 | XRAY | DENTSPLY SIRONA Inc. | 2.76B | -3.43% | 3,653,141 | 3.68B |
| 217 | SUPN | Supernus Pharmaceuticals, Inc. | 2.73B | 8.46% | 1,671,843 | 830.44M |
| 218 | KOD | Kodiak Sciences Inc. | 2.72B | 1.68% | 525,287 | - |
| 219 | BEAM | Beam Therapeutics Inc. | 2.70B | -4.51% | 2,056,910 | 156.04M |
| 220 | ESTA | Establishment Labs Holdings Inc. | 2.69B | -3.55% | 912,792 | 229.58M |
| 221 | ATAI | AtaiBeckley Inc. | 2.67B | 0.56% | 9,548,975 | 3.49M |
| 222 | TMDX | TransMedics Group, Inc. | 2.65B | -5.28% | 2,954,403 | 668.47M |
| 223 | TRVI | Trevi Therapeutics, Inc. | 2.65B | -0.53% | 1,501,887 | - |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | 0.29% | 354,602 | 535.08M |
| 225 | PLSE | Pulse Biosciences, Inc. | 2.62B | -0.71% | 225,402 | 751.00K |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.61B | 1.74% | 1,343,967 | 36.77M |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | -0.07% | 164,365 | 1.46B |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.51B | 1.88% | 610,198 | 1.10B |
| 229 | UFPT | UFP Technologies, Inc. | 2.49B | -3.82% | 341,471 | 631.64M |
| 230 | NEOG | Neogen Corporation | 2.49B | -3.47% | 3,299,143 | 870.40M |
| 231 | NKTR | Nektar Therapeutics | 2.47B | 0.45% | 581,029 | 55.63M |
| 232 | PGEN | Precigen, Inc. | 2.47B | 5.51% | 16,936,790 | 85.72M |
| 233 | PGNY | Progyny, Inc. | 2.46B | -0.35% | 641,816 | 1.29B |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -3.41% | 2,642,398 | 717.00M |
| 235 | AXGN | Axogen, Inc. | 2.43B | -1.61% | 968,881 | 251.17M |
| 236 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.43B | -0.09% | 1,772,236 | -665.00K |
| 237 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | 1.32% | 504,319 | - |
| 238 | KLRA | Kailera Therapeutics, Inc. | 2.35B | 0.33% | 296,702 | - |
| 239 | CDNA | CareDx, Inc. | 2.35B | -3.38% | 1,119,355 | 458.09M |
| 240 | BHC | Bausch Health Companies Inc. | 2.35B | -2.33% | 4,249,748 | 10.85B |
| 241 | HTFL | HeartFlow, Inc. | 2.34B | -0.40% | 907,707 | 191.42M |
| 242 | COAG | Hemab Therapeutics Holdings, Inc. | 2.34B | 7.67% | 353,630 | - |
| 243 | PHVS | Pharvaris N.V. | 2.34B | -1.33% | 386,925 | - |
| 244 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | 0.42% | 5,763,732 | - |
| 245 | VRDN | Viridian Therapeutics, Inc. | 2.33B | 1.10% | 1,666,707 | 70.92M |
| 246 | VCEL | Vericel Corporation | 2.32B | -2.11% | 468,924 | 306.30M |
| 247 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.32B | 0.55% | 6,093,801 | 940.61M |
| 248 | URGN | UroGen Pharma Ltd. | 2.27B | 16.31% | 2,480,807 | 188.73M |
| 249 | BFLY | Butterfly Network, Inc. | 2.24B | -4.43% | 5,804,176 | 112.14M |
| 250 | PVLA | Palvella Therapeutics, Inc. | 2.23B | 1.92% | 147,342 | - |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | -1.39% | 1,282,166 | 959.90M |
| 252 | NUVB | Nuvation Bio Inc. | 2.22B | -1.09% | 5,497,214 | 143.05M |
| 253 | CLOV | Clover Health Investments, Corp. | 2.18B | -3.04% | 4,605,533 | 2.48B |
| 254 | VERA | Vera Therapeutics, Inc. | 2.18B | 1.34% | 3,213,832 | - |
| 255 | ADMA | ADMA Biologics, Inc. | 2.15B | 3.93% | 3,800,479 | 512.28M |
| 256 | SION | Sionna Therapeutics, Inc. | 2.14B | -5.21% | 757,883 | - |
| 257 | ADUS | Addus HomeCare Corporation | 2.13B | 2.46% | 284,808 | 1.48B |
| 258 | WGS | GeneDx Holdings Corp. | 2.08B | -1.40% | 867,131 | 454.43M |
| 259 | HCM | HUTCHMED (China) Limited | 2.08B | -0.17% | 21,132 | 549.12M |
| 260 | TSHA | Taysha Gene Therapies, Inc. | 2.07B | 4.19% | 2,181,065 | 7.47M |
| 261 | ZLAB | Zai Lab Limited | 2.06B | -0.65% | 195,279 | 453.28M |
| 262 | MD | Pediatrix Medical Group, Inc. | 2.06B | 5.18% | 1,500,644 | 1.95B |
| 263 | STOK | Stoke Therapeutics, Inc. | 2.06B | 0.82% | 635,025 | 27.59M |
| 264 | BHVN | Biohaven Ltd. | 2.05B | -0.87% | 1,433,183 | - |
| 265 | MESO | Mesoblast Limited | 2.05B | 1.08% | 80,710 | 65.38M |
| 266 | RAPP | Rapport Therapeutics, Inc. | 2.04B | 0.57% | 210,108 | 20.00M |
| 267 | AVAH | Aveanna Healthcare Holdings Inc. | 2.03B | -0.32% | 1,857,265 | 2.52B |
| 268 | NEO | NeoGenomics, Inc. | 2.02B | -3.44% | 1,824,488 | 766.30M |
| 269 | ZBIO | Zenas BioPharma, Inc. | 2.01B | 1.40% | 411,111 | 10.00M |
| 270 | ATRC | AtriCure, Inc. | 2.00B | 0.87% | 754,744 | 569.62M |
| 271 | GHRS | GH Research PLC | 2.00B | 0.03% | 232,226 | - |
| 272 | NBTX | Nanobiotix S.A. | 1.99B | 0.38% | 88,348 | 38.27M |
| 273 | SGRY | Surgery Partners, Inc. | 1.99B | -2.11% | 1,397,181 | 3.34B |
| 274 | ALMR | Alamar Biosciences, Inc. | 1.96B | 4.57% | 201,180 | 87.16M |
| 275 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | 1.74% | 1,025,088 | 298.30M |
| 276 | IOVA | Iovance Biotherapeutics, Inc. | 1.94B | -0.46% | 15,595,198 | 285.61M |
| 277 | DMRA | Damora Therapeutics, Inc. | 1.90B | 2.70% | 607,293 | - |
| 278 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 0.38% | 915,636 | 98.34M |
| 279 | FBRX | Forte Biosciences, Inc. | 1.87B | 0.07% | 1,366,910 | - |
| 280 | NVCR | NovoCure Limited | 1.87B | -1.35% | 1,234,123 | 699.19M |
| 281 | OCUL | Ocular Therapeutix, Inc. | 1.87B | -1.05% | 1,599,950 | 52.06M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.86B | 3.32% | 361,950 | 367.34M |
| 283 | GENB | Generate Biomedicines, Inc. | 1.86B | 1.47% | 440,922 | 26.48M |
| 284 | PRGO | Perrigo Company plc | 1.84B | 23.10% | 8,189,976 | 4.14B |
| 285 | CMPS | COMPASS Pathways plc | 1.83B | 15.08% | 7,682,476 | - |
| 286 | FTRE | Fortrea Holdings Inc. | 1.81B | 5.89% | 1,911,574 | 2.68B |
| 287 | KARD | Kardigan, Inc. | 1.81B | -1.17% | 171,372 | - |
| 288 | ABCL | AbCellera Biologics Inc. | 1.81B | -2.79% | 4,625,462 | 66.17M |
| 289 | LMAT | LeMaitre Vascular, Inc. | 1.81B | -25.32% | 2,185,210 | 262.43M |
| 290 | AGL | agilon health, inc. | 1.80B | 13.79% | 1,115,796 | 5.92B |
| 291 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 4.40% | 3,775,172 | 252.25M |
| 292 | OBX | Obsidian Therapeutics, Inc. | 1.76B | -16.15% | 18,367 | - |
| 293 | SEPN | Septerna, Inc. | 1.75B | -0.56% | 442,958 | 72.26M |
| 294 | LKFT | Lakefront Biotherapeutics NV | 1.74B | -1.40% | 319,782 | 1.20B |
| 295 | ENOV | Enovis Corporation | 1.74B | -2.20% | 1,504,408 | 2.30B |
| 296 | INSP | Inspire Medical Systems, Inc. | 1.74B | -6.31% | 1,448,167 | 898.74M |
| 297 | BCAX | Bicara Therapeutics Inc. | 1.70B | -0.80% | 818,324 | - |
| 298 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -4.23% | 17,458,815 | 54.86M |
| 299 | ANIP | ANI Pharmaceuticals, Inc. | 1.69B | 0.86% | 205,406 | 923.71M |
| 300 | IMCR | Immunocore Holdings plc | 1.69B | 0.15% | 518,649 | 412.81M |
| 301 | OMCL | Omnicell, Inc. | 1.69B | 0.05% | 699,654 | 1.25B |
| 302 | ZYME | Zymeworks Inc. | 1.68B | 3.12% | 488,396 | 81.26M |
| 303 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | -2.81% | 3,109,305 | 1.97B |
| 304 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.65B | -0.31% | 1,199,451 | 204.73M |
| 305 | BLFS | BioLife Solutions, Inc. | 1.65B | 3.94% | 600,919 | 101.66M |
| 306 | TRAX | First Tracks Biotherapeutics, Inc. | 1.64B | 2.04% | 940,023 | - |
| 307 | ANAB | AnaptysBio, Inc. | 1.63B | -0.25% | 316,638 | 232.39M |
| 308 | TRLV | Trulieve Cannabis Corp. | 1.62B | -5.06% | 1,044,830 | 1.17B |
| 309 | ASTH | Astrana Health, Inc. | 1.61B | 0.45% | 512,519 | 3.53B |
| 310 | ARDT | Ardent Health, Inc. | 1.58B | 3.81% | 1,016,029 | 6.41B |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.57B | -1.34% | 788,101 | 1.86B |
| 312 | AAPG | Ascentage Pharma Group International | 1.57B | 0.99% | 4,617 | 82.08M |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.54B | 0.72% | 254,328 | 20.00M |
| 314 | VIR | Vir Biotechnology, Inc. | 1.54B | -0.65% | 1,452,638 | 303.23M |
| 315 | TYRA | Tyra Biosciences, Inc. | 1.53B | -20.97% | 2,741,985 | - |
| 316 | NTLA | Intellia Therapeutics, Inc. | 1.53B | -3.09% | 4,734,414 | 66.09M |
| 317 | INVA | Innoviva, Inc. | 1.51B | -1.68% | 702,942 | 440.00M |
| 318 | INNV | InnovAge Holding Corp. | 1.51B | 2.21% | 170,540 | 949.17M |
| 319 | ATEC | Alphatec Holdings, Inc. | 1.48B | -7.54% | 5,220,687 | 815.05M |
| 320 | CNMD | CONMED Corporation | 1.48B | -2.18% | 431,185 | 1.37B |
| 321 | XNCR | Xencor, Inc. | 1.47B | -0.40% | 826,086 | 104.97M |
| 322 | XERS | Xeris Biopharma Holdings, Inc. | 1.47B | -0.98% | 1,750,710 | 314.85M |
| 323 | HROW | Harrow, Inc. | 1.47B | -1.05% | 301,807 | 268.68M |
| 324 | KMTS | Kestra Medical Technologies, Ltd. | 1.47B | -3.36% | 350,953 | 95.13M |
| 325 | PAHC | Phibro Animal Health Corporation | 1.46B | -1.59% | 158,646 | 1.50B |
| 326 | MLTX | MoonLake Immunotherapeutics | 1.45B | -2.12% | 579,213 | - |
| 327 | PSNL | Personalis, Inc. | 1.44B | - | 1,470,566 | 69.67M |
| 328 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -2.79% | 500,447 | - |
| 329 | ABSI | Absci Corporation | 1.42B | -0.94% | 2,101,267 | 1.84M |
| 330 | AVLN | Avalyn Pharma Inc. | 1.42B | 4.13% | 188,931 | - |
| 331 | SVRA | Savara Inc. | 1.40B | 1.85% | 1,602,633 | - |
| 332 | AZTA | Azenta, Inc. | 1.39B | 5.61% | 1,108,242 | 613.81M |
| 333 | IART | Integra LifeSciences Holdings Corporation | 1.38B | -1.23% | 606,022 | 1.65B |
| 334 | PNTG | The Pennant Group, Inc. | 1.35B | 0.52% | 684,569 | 1.10B |
| 335 | TNDM | Tandem Diabetes Care, Inc. | 1.34B | -3.02% | 3,470,810 | 1.03B |
| 336 | ALVO | Alvotech | 1.34B | -2.08% | 741,941 | 562.04M |
| 337 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | -4.01% | 2,138,163 | - |
| 338 | IMTX | Immatics N.V. | 1.34B | 4.16% | 676,490 | 43.00M |
| 339 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | -2.92% | 1,980,638 | 42.95M |
| 340 | MNKD | MannKind Corporation | 1.31B | 3.54% | 6,833,550 | 393.63M |
| 341 | LBRX | LB Pharmaceuticals Inc | 1.29B | 0.07% | 317,746 | - |
| 342 | JBIO | Jade Biosciences, Inc. | 1.29B | 1.64% | 1,265,241 | - |
| 343 | BVS | Bioventus Inc. | 1.27B | 13.71% | 2,529,241 | 581.85M |
| 344 | AMN | AMN Healthcare Services, Inc. | 1.27B | -1.35% | 793,213 | 3.42B |
| 345 | AORT | Artivion, Inc. | 1.27B | -2.71% | 964,007 | 458.69M |
| 346 | NVAX | Novavax, Inc. | 1.27B | 0.52% | 3,632,834 | 596.34M |
| 347 | ETON | Eton Pharmaceuticals, Inc. | 1.26B | 0.31% | 389,007 | 86.93M |
| 348 | TDOC | Teladoc Health, Inc. | 1.26B | 3.28% | 5,631,840 | 2.49B |
| 349 | AKTS | Aktis Oncology, Inc. | 1.25B | -0.83% | 248,420 | 8.28M |
| 350 | AHG | Akso Health Group | 1.25B | 2.38% | 1,576 | 13.83M |
| 351 | FRNM | Freenome, Inc. | 1.23B | - | 1,226,538 | 34.24M |
| 352 | INBX | Inhibrx Biosciences, Inc. | 1.23B | 0.43% | 142,142 | 1.30M |
| 353 | SDGR | Schrödinger, Inc. | 1.23B | 4.79% | 1,717,917 | 259.04M |
| 354 | CERT | Certara, Inc. | 1.22B | 2.69% | 3,410,090 | 421.75M |
| 355 | ARDX | Ardelyx, Inc. | 1.21B | -2.00% | 3,109,710 | 427.68M |
| 356 | VOR | Vor Biopharma Inc. | 1.21B | 0.09% | 723,693 | - |
| 357 | DRTS | Alpha Tau Medical Ltd. | 1.20B | 1.38% | 344,099 | - |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.20B | 4.25% | 119,427 | - |
| 359 | QDEL | QuidelOrtho Corporation | 1.19B | -0.48% | 1,212,516 | 2.66B |
| 360 | USPH | U.S. Physical Therapy, Inc. | 1.18B | 2.44% | 266,677 | 804.27M |
| 361 | IRMD | IRADIMED CORPORATION | 1.17B | -1.36% | 148,483 | 86.34M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | 0.07% | 738,926 | - |
| 363 | WVE | Wave Life Sciences Ltd. | 1.17B | -1.17% | 1,837,193 | 65.37M |
| 364 | MGTX | MeiraGTx Holdings plc | 1.16B | 2.12% | 420,148 | 79.76M |
| 365 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | 0.03% | 402,417 | 796.33M |
| 366 | STAA | STAAR Surgical Company | 1.14B | -5.22% | 1,233,542 | 290.38M |
| 367 | OMDA | Omada Health, Inc. | 1.14B | -5.30% | 2,078,670 | 283.30M |
| 368 | GDRX | GoodRx Holdings, Inc. | 1.11B | -2.10% | 2,174,301 | 785.23M |
| 369 | PRCT | PROCEPT BioRobotics Corporation | 1.10B | 5.80% | 5,458,861 | 337.34M |
| 370 | ANRO | Alto Neuroscience, Inc. | 1.09B | -0.71% | 248,886 | - |
| 371 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.09B | -1.61% | 3,974,294 | 69.64M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.09B | -0.44% | 303,182 | 1.03B |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | 0.34% | 465,624 | - |
| 374 | NUTX | Nutex Health Inc. | 1.08B | -0.34% | 94,009 | 879.95M |
| 375 | IVA | Inventiva S.A. | 1.06B | 4.66% | 707,576 | 7.94M |
| 376 | APMD | Apnimed, Inc. | 1.06B | 3.11% | 486,272 | 120.15M |
| 377 | SANA | Sana Biotechnology, Inc. | 1.05B | 3.24% | 3,008,941 | - |
| 378 | GERN | Geron Corporation | 1.05B | 21.64% | 36,080,016 | 204.56M |
| 379 | EYPT | EyePoint, Inc. | 1.03B | 4.97% | 2,450,068 | 2.79M |
| 380 | CRON | Cronos Group Inc. | 1.01B | -3.20% | 1,718,000 | 159.54M |
| 381 | OLMA | Olema Pharmaceuticals, Inc. | 1.01B | -1.53% | 722,435 | - |
| 382 | OPK | OPKO Health, Inc. | 1.01B | 3.05% | 2,680,546 | 587.90M |
| 383 | ODTX | Odyssey Therapeutics, Inc. | 1.00B | 4.66% | 131,575 | 1.06M |
| 384 | AVTX | Avalo Therapeutics, Inc. | 996.69M | 1.67% | 734,515 | 59.00K |
| 385 | REPL | Replimune Group, Inc. | 993.30M | -0.76% | 2,862,134 | - |
| 386 | PCRX | Pacira BioSciences, Inc. | 991.37M | -9.96% | 1,701,967 | 746.16M |
| 387 | JANX | Janux Therapeutics, Inc. | 975.75M | 0.25% | 546,037 | 13.73M |
| 388 | GMRS | GMR Solutions Inc. | 950.41M | -2.16% | 186,006 | 5.83B |
| 389 | ATTO | Attovia Therapeutics, Inc. | 942.34M | 28.82% | 4,907,296 | 1.35M |
| 390 | CSTL | Castle Biosciences, Inc. | 928.71M | -2.50% | 520,196 | 357.28M |
| 391 | OMER | Omeros Corporation | 915.55M | -2.24% | 1,116,889 | 9.89M |
| 392 | ABUS | Arbutus Biopharma Corporation | 912.62M | 4.52% | 1,704,821 | 191.45M |
| 393 | AMPH | Amphastar Pharmaceuticals, Inc. | 892.44M | 1.71% | 351,618 | 720.53M |
| 394 | ACRS | Aclaris Therapeutics, Inc. | 888.26M | 6.35% | 5,676,031 | 8.37M |
| 395 | ANNX | Annexon, Inc. | 879.83M | 0.75% | 1,770,793 | - |
| 396 | TBPH | Theravance Biopharma, Inc. | 875.90M | 0.12% | 400,375 | 109.78M |
| 397 | TALK | Talkspace, Inc. | 874.42M | 1.36% | 1,107,787 | 238.37M |
| 398 | INMD | InMode Ltd. | 874.28M | -1.04% | 533,620 | 374.63M |
| 399 | AHCO | AdaptHealth Corp. | 866.49M | -3.20% | 9,996,027 | 3.36B |
| 400 | SLDB | Solid Biosciences Inc. | 859.47M | 1.28% | 876,404 | - |
| 401 | DSGN | Design Therapeutics, Inc. | 849.23M | 2.80% | 472,064 | - |
| 402 | DBVT | DBV Technologies S.A. | 830.24M | 3.87% | 407,305 | 5.04M |
| 403 | HSTM | HealthStream, Inc. | 818.32M | -6.01% | 246,108 | 321.12M |
| 404 | KURA | Kura Oncology, Inc. | 816.72M | -2.85% | 1,281,242 | 71.64M |
| 405 | SIBN | SI-BONE, Inc. | 808.53M | -2.17% | 623,881 | 213.60M |
| 406 | GLAS | Glass House Brands Inc. | 803.94M | -8.04% | 637,908 | 177.68M |
| 407 | MNPR | Monopar Therapeutics Inc. | 798.70M | 0.65% | 182,731 | - |
| 408 | AURA | Aura Biosciences, Inc. | 791.95M | 0.42% | 314,870 | - |
| 409 | SGP | SpyGlass Pharma, Inc. | 791.70M | -1.78% | 65,128 | - |
| 410 | AVR | Anteris Technologies Global Corp. | 784.52M | -2.78% | 584,542 | 1.85M |
| 411 | SSII | SS Innovations International, Inc. | 770.51M | 0.52% | 109,224 | 48.47M |
| 412 | DRUG | Bright Minds Biosciences Inc. | 766.86M | 3.43% | 117,332 | - |
| 413 | CADL | Candel Therapeutics, Inc. | 766.41M | -0.48% | 750,663 | - |
| 414 | PHAR | Pharming Group N.V. | 758.20M | 4.04% | 5,278 | 366.48M |
| 415 | RIGL | Rigel Pharmaceuticals, Inc. | 756.16M | 4.60% | 748,876 | 276.79M |
| 416 | TENX | Tenax Therapeutics, Inc. | 747.53M | -5.57% | 2,250,025 | - |
| 417 | CTMX | CytomX Therapeutics, Inc. | 729.30M | 0.90% | 2,030,830 | 35.54M |
| 418 | OCS | Oculis Holding AG | 728.88M | 0.67% | 579,287 | 1.40M |
| 419 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 717.76M | 1.01% | 147,403 | - |
| 420 | NGNE | Neurogene Inc. | 716.97M | 4.56% | 167,582 | 925.00K |
| 421 | CLYM | Climb Bio, Inc. | 714.04M | -0.72% | 1,103,992 | - |
| 422 | PHR | Phreesia, Inc. | 710.22M | 0.44% | 627,185 | 495.59M |
| 423 | AGMB | AgomAb Therapeutics NV | 705.23M | -2.78% | 29,060 | - |
| 424 | EVO | Evotec SE | 703.94M | 1.54% | 454,958 | 859.03M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 694.58M | 1.30% | 35,251 | 117.05M |
| 426 | CBLL | CeriBell, Inc. | 693.97M | -1.24% | 181,522 | 95.07M |
| 427 | ACHV | Achieve Life Sciences, Inc. | 683.71M | 2.94% | 898,238 | - |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 683.15M | -3.71% | 2,209,856 | 361.51M |
| 429 | IMMX | Immix Biopharma, Inc. | 679.15M | 2.25% | 1,316,898 | - |
| 430 | TCMD | Tactile Systems Technology, Inc. | 676.24M | -0.53% | 162,144 | 343.52M |
| 431 | CBIO | Crescent Biopharma, Inc. | 674.97M | -3.72% | 184,348 | 11.88M |
| 432 | ALLO | Allogene Therapeutics, Inc. | 673.05M | 2.63% | 5,056,052 | 22.00K |
| 433 | PHAT | Phathom Pharmaceuticals, Inc. | 653.71M | -2.60% | 1,652,474 | 239.66M |
| 434 | HELP | Cybin Inc. | 652.69M | 13.47% | 2,814,462 | - |
| 435 | RGNX | REGENXBIO Inc. | 647.88M | 1.94% | 1,521,969 | 87.82M |
| 436 | FTH | Faeth Therapeutics, Inc. | 633.90M | -3.57% | 383,418 | - |
| 437 | NVCT | Nuvectis Pharma, Inc. | 627.52M | -4.18% | 220,131 | - |
| 438 | BBNX | Beta Bionics, Inc. | 625.81M | -4.53% | 897,075 | 119.01M |
| 439 | ZVRA | Zevra Therapeutics, Inc. | 622.48M | 0.10% | 781,393 | 136.07M |
| 440 | ANGO | AngioDynamics, Inc. | 621.64M | -0.99% | 538,441 | 320.17M |
| 441 | BWAY | BrainsWay Ltd. | 618.63M | -5.00% | 83,591 | 56.22M |
| 442 | DNA | Ginkgo Bioworks Holdings, Inc. | 612.09M | - | 990,369 | 132.42M |
| 443 | MDXG | MiMedx Group, Inc. | 606.36M | -2.58% | 1,468,635 | 355.17M |
| 444 | TLRY | Tilray Brands, Inc. | 600.09M | -4.63% | 4,652,563 | 915.45M |
| 445 | ALT | Altimmune, Inc. | 589.26M | -1.30% | 3,163,967 | 36.00K |
| 446 | MPLT | MapLight Therapeutics, Inc. | 585.87M | -0.15% | 886,896 | - |
| 447 | KIDS | OrthoPediatrics Corp. | 582.55M | 6.85% | 709,503 | 252.72M |
| 448 | CRMD | CorMedix Inc. | 581.33M | -1.46% | 615,544 | 400.05M |
| 449 | CTNM | Contineum Therapeutics, Inc. | 574.47M | -3.96% | 247,882 | - |
| 450 | RLMD | Relmada Therapeutics, Inc. | 570.60M | -0.55% | 827,308 | - |
| 451 | STTK | Shattuck Labs, Inc. | 565.14M | -6.94% | 967,259 | 1.00M |
| 452 | ARTV | Artiva Biotherapeutics, Inc. | 563.14M | 4.70% | 548,574 | 251.00K |
| 453 | TECX | Tectonic Therapeutic, Inc. | 557.77M | 1.34% | 125,943 | - |
| 454 | PRME | Prime Medicine, Inc. | 556.30M | 3.36% | 3,145,004 | 4.03M |
| 455 | ARVN | Arvinas, Inc. | 549.24M | -6.67% | 1,571,545 | 316.70M |
| 456 | WEAV | Weave Communications, Inc. | 541.05M | -1.02% | 693,984 | 248.72M |
| 457 | CTKB | Cytek Biosciences, Inc. | 539.82M | -2.34% | 993,960 | 206.71M |
| 458 | FDMT | 4D Molecular Therapeutics, Inc. | 537.40M | 0.19% | 664,783 | 88.24M |
| 459 | SOPH | SOPHiA GENETICS SA | 536.31M | -7.89% | 722,080 | 86.17M |
| 460 | ZURA | Zura Bio Limited | 535.79M | -0.88% | 852,105 | - |
| 461 | SGMT | Sagimet Biosciences Inc. | 533.54M | 8.14% | 2,137,338 | - |
| 462 | SPRY | ARS Pharmaceuticals, Inc. | 532.27M | 0.75% | 2,542,540 | 98.99M |
| 463 | SLN | Silence Therapeutics plc | 530.91M | 0.63% | 452,235 | 839.00K |
| 464 | ANL | Adlai Nortye Ltd. | 522.80M | 0.54% | 111,496 | 5.00M |
| 465 | VREX | Varex Imaging Corporation | 522.19M | 0.16% | 274,424 | 857.50M |
| 466 | SRTA | Strata Critical Medical, Inc. | 517.53M | 5.03% | 2,513,953 | 255.98M |
| 467 | EIKN | Eikon Therapeutics, Inc. | 517.02M | -0.10% | 277,036 | - |
| 468 | VSTM | Verastem, Inc. | 515.82M | 1.03% | 1,554,979 | 49.59M |
| 469 | ASMB | Assembly Biosciences, Inc. | 510.82M | 0.36% | 113,349 | 71.10M |
| 470 | FLGT | Fulgent Genetics, Inc. | 509.86M | -0.11% | 372,435 | 323.93M |
| 471 | AUTL | Autolus Therapeutics plc | 505.67M | -2.56% | 1,576,995 | 92.62M |
| 472 | PROK | ProKidney Corp. | 504.44M | 2.45% | 611,090 | 889.00K |
| 473 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 474 | STLN | Starling Oncology, Inc. | 502.91M | -2.71% | 1,012,708 | 545.76M |
| 475 | QTTB | Q32 Bio Inc. | 490.81M | 2.04% | 651,498 | 53.74M |
| 476 | OVID | Ovid Therapeutics Inc. | 489.00M | 3.15% | 2,253,579 | 7.12M |
| 477 | RZLT | Rezolute, Inc. | 488.90M | -5.84% | 1,374,275 | - |
| 478 | VALN | Valneva SE | 488.51M | 1.75% | 48,840 | 180.25M |
| 479 | BIOA | BioAge Labs, Inc. | 488.09M | -1.96% | 1,128,039 | 10.36M |
| 480 | AQST | Aquestive Therapeutics, Inc. | 471.13M | 0.40% | 1,466,034 | 50.27M |
| 481 | IKT | Inhibikase Therapeutics, Inc. | 469.01M | -1.64% | 1,108,540 | 1.00 |
| 482 | EVMN | Evommune, Inc. | 468.96M | -0.69% | 637,823 | 10.00M |
| 483 | SI | Shoulder Innovations, Inc. | 468.68M | -0.40% | 54,864 | 53.89M |
| 484 | NPCE | NeuroPace, Inc. | 467.08M | -3.11% | 274,463 | 99.53M |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 464.48M | -1.80% | 576,962 | - |
| 486 | CERS | Cerus Corporation | 457.46M | 3.65% | 3,261,942 | 221.55M |
| 487 | SLBT | SL Science Holding Limited | 452.55M | -9.09% | 96,053 | 3.27M |
| 488 | PRLD | Prelude Therapeutics Incorporated | 450.27M | 0.44% | 158,285 | 16.72M |
| 489 | SCTX | Scribe Therapeutics Inc. | 448.97M | 7.89% | 266,587 | 36.28M |
| 490 | NNNN | Anbio Biotechnology | 445.50M | - | 17,293 | 8.65M |
| 491 | CTEV | Claritev Corporation | 445.46M | -1.02% | 63,922 | 978.76M |
| 492 | PRTA | Prothena Corporation plc | 444.48M | - | 489,491 | 57.94M |
| 493 | CABA | Cabaletta Bio, Inc. | 441.88M | -2.17% | 10,228,201 | - |
| 494 | DCTH | Delcath Systems, Inc. | 436.01M | -3.88% | 433,019 | 90.44M |
| 495 | BNTC | Benitec Biopharma Inc. | 435.96M | 1.36% | 95,223 | - |
| 496 | OCGN | Ocugen, Inc. | 433.31M | -2.29% | 6,304,969 | 4.47M |
| 497 | NRC | NRC Health | 432.22M | -0.26% | 101,825 | 140.00M |
| 498 | LRMR | Larimar Therapeutics, Inc. | 427.97M | -0.24% | 1,281,053 | - |
| 499 | VTVT | vTv Therapeutics Inc. | 426.76M | 7.27% | 102,677 | 36.84M |
| 500 | OFIX | Orthofix Medical Inc. | 424.43M | -14.59% | 1,193,270 | 833.19M |